Bret K. Purcell

431 total citations
19 papers, 273 citations indexed

About

Bret K. Purcell is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Bret K. Purcell has authored 19 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Genetics. Recurrent topics in Bret K. Purcell's work include Bacillus and Francisella bacterial research (10 papers), Viral Infections and Outbreaks Research (5 papers) and Antibiotic Resistance in Bacteria (3 papers). Bret K. Purcell is often cited by papers focused on Bacillus and Francisella bacterial research (10 papers), Viral Infections and Outbreaks Research (5 papers) and Antibiotic Resistance in Bacteria (3 papers). Bret K. Purcell collaborates with scholars based in United States, United Kingdom and Hungary. Bret K. Purcell's co-authors include Henry S. Heine, Patricia L. Worsham, Bruce E. Ivins, Elizabeth K. Leffel, Arthur M. Friedlander, Nancy Twenhafel, James V. Lawler, Mary E. Wright, Nicholas J. Vietri and Amy E. Baker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Bret K. Purcell

17 papers receiving 251 citations

Peers

Countries citing papers authored by Bret K. Purcell

Since Specialization

Citations

This map shows the geographic impact of Bret K. Purcell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bret K. Purcell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bret K. Purcell more than expected).

Fields of papers citing papers by Bret K. Purcell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bret K. Purcell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bret K. Purcell. The network helps show where Bret K. Purcell may publish in the future.

Co-authorship network of co-authors of Bret K. Purcell

This figure shows the co-authorship network connecting the top 25 collaborators of Bret K. Purcell. A scholar is included among the top collaborators of Bret K. Purcell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bret K. Purcell. Bret K. Purcell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant Burkholderia pseudomallei in a murine infection model 2024 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, Bret K. Purcell, (unknown), (unknown), (unknown), A. R. Chase, (unknown), Michael Vicchiarelli, George L. Drusano, Pei Zhou	0
2	Omadacycline is active in vitro and in vivo against ciprofloxacin-resistant Bacillus anthracis 2024 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, George L. Drusano, Bret K. Purcell, (unknown), Sébastien Tanaka, Alisa W. Serio	3
3	Are Ingested B. anthracis Spores a Contribution to Anthrax Disease Progression in the Mouse Aerosol Challenge Model? 2022 ·Henry S. Heine, (unknown), (unknown), Bruce E. Ivins, Bret K. Purcell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Detecting Pathogen Exposure During the Non-symptomatic Incubation Period Using Physiological Data: Proof of Concept in Non-human Primates 2021 ·Frontiers in Physiology ·Shakti K. Davis, Lauren Milechin, (unknown), (unknown), (unknown), Siddharth Samsi, Lisa E. Hensley, Arthur J. Goff, John C. Trefry, Sara C. Johnston, Bret K. Purcell, Catherine Cabrera, (unknown), Albert Reuther, Kajal Claypool, Franco Rossi, Anna N. Honko, William D. Pratt, Albert Swiston	3
5	Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine 2021 ·Vaccine ·(unknown), Anthony P. Cardile, (unknown), Isaac Downs, Ronald B. Reisler, Ellen F. Boudreau, Mark G. Kortepeter, (unknown), (unknown), (unknown), Niranjan Kanesa-thasan, Robert G. Rivard, (unknown), (unknown), Sarah L. Norris, Bret K. Purcell, Phillip R. Pittman, David Saunders, (unknown)	7
6	2773. Safety and Immunogenicity Study of Eastern Equine Encephalitis Vaccine 2019 ·Open Forum Infectious Diseases ·(unknown), Ronald B. Reisler, Bret K. Purcell, Robert G. Rivard, Anthony P. Cardile, (unknown), Sarah L. Norris, (unknown)	2
7	In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods 2017 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, (unknown), (unknown), Bret K. Purcell	19
8	In Vitro Antibiotic Susceptibilities of Yersinia pestis Determined by Broth Microdilution following CLSI Methods 2015 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, Jeremy R. Hershfield, C. Marchand, (unknown), (unknown), Bret K. Purcell, Patricia L. Worsham	24
9	Real-time Monitoring of Cardiovascular Function in Rhesus Macaques Infected With Zaire ebolavirus 2011 ·The Journal of Infectious Diseases ·Mark G. Kortepeter, James V. Lawler, Anna N. Honko, Mike Bray, Joshua C. Johnson, Bret K. Purcell, Gene G. Olinger, Robert G. Rivard, Matthew J. Hepburn, Lisa E. Hensley	27
10	Efficacy of Daptomycin against Bacillus anthracis in a Murine Model of Anthrax Spore Inhalation 2010 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, (unknown), (unknown), Bret K. Purcell, W. Russell Byrne	14
11	Activity of Dalbavancin against Bacillus anthracis In Vitro and in a Mouse Inhalation Anthrax Model 2010 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, Bret K. Purcell, (unknown), (unknown), Beth P. Goldstein	10
12	A Short Course of Antibiotic Treatment Is Effective in Preventing Death from Experimental Inhalational Anthrax after Discontinuing Antibiotics 2008 ·The Journal of Infectious Diseases ·Nicholas J. Vietri, Bret K. Purcell, (unknown), (unknown), Elizabeth K. Leffel, Nancy Twenhafel, Bruce E. Ivins, Mark D. Kellogg, W.M. Webster, Mary E. Wright, Arthur M. Friedlander	23
13	An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock 2008 ·PubMed ·Garry L. Morefield, Ralph F. Tammariello, Bret K. Purcell, Patricia L. Worsham, Jennifer Chapman, Leonard A. Smith, Jason B. Alarcon, John A. Mikszta, Robert G. Ulrich	38
14	Pathogenesis and Sepsis Caused by Organisms Potentially Utilized as Biologic Weapons: Opportunities for Targeted Intervention. 2007 ·Current Drug Targets ·Matthew J. Hepburn, Bret K. Purcell, Jason Paragas	2
15	The effect of harp music on heart rate, mean blood pressure, respiratory rate, and body temperature in the African green monkey 2006 ·Journal of Medical Primatology ·(unknown), (unknown), Bret K. Purcell	16
16	Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax 2006 ·Proceedings of the National Academy of Sciences ·Nicholas J. Vietri, Bret K. Purcell, James V. Lawler, Elizabeth K. Leffel, (unknown), (unknown), Nancy Twenhafel, Bruce E. Ivins, Henry S. Heine, (unknown), Mary E. Wright, Arthur M. Friedlander	54
17	Experience with Directly Observed Prophylaxis Using Erythromycin in Military Trainees Exposed to Pertussis 2004 ·Military Medicine ·Bret K. Purcell, David P. Dooley, Paula J. Gray, (unknown), (unknown)	3
18	Centers for Disease Control and Prevention Group O1 Bacterium–Associated Pneumonia Complicated by Bronchopulmonary Fistula and Bacteremia 1999 ·Clinical Infectious Diseases ·Bret K. Purcell, David P. Dooley	1
19	Rapidly Fatal Infection Due toPhotobacterium (Vibrio) damsela 1997 ·Clinical Infectious Diseases ·Susan Fraser, Bret K. Purcell, (unknown), Amy E. Baker, A. Christian Whelen	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact